MiRNA in bladder carcinogenesis: A review

doi:10.5410/wjcu.v3.i3.238

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7436)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

455

WORD

207

HTML

3928

Figures (1-4)

596

Sum=5186

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1045

Download

1205

Sum=2250

Nov 24, 2014 (publication date) through Nov 6, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Clinical Urology

ISSN

2219-2816

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Urol. Nov 24, 2014; 3(3): 238-248
Published online Nov 24, 2014. doi: 10.5410/wjcu.v3.i3.238

Full Size Figure Download Figure

Figure 3 MiR-100 in low-grade non-invasive urothelial carcinoma carcinogenesis. Under-expression of miR-100 leads to FGFR3 gene over-expression, stimulus to PI3K/AKT/STAT pathway and low-grade non-invasive tumor development. Adapted by Wu[19], 2009. FGFR3: Fibroblastic growth factor receptor 3; UC: Urothelial carcinoma.

Citation: Dip N, Reis ST, Viana NI, Morais DR, Moura CM, Katz B, Abe DK, Iscaife A, Silva IA, Srougi M, Leite KR. MiRNA in bladder carcinogenesis: A review. World J Clin Urol 2014; 3(3): 238-248
URL: https://www.wjgnet.com/2219-2816/full/v3/i3/238.htm
DOI: https://dx.doi.org/10.5410/wjcu.v3.i3.238